- Home
- LENZ vs IRMD Comparison
LENZ vs IRMD Comparison
Compare LENZ & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- IRMD
- Stock Information
- Founded
- LENZ 2019
- IRMD 1992
- Country
- LENZ United States
- IRMD United States
- Employees
- LENZ N/A
- IRMD N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- IRMD Medical/Dental Instruments
- Sector
- LENZ Health Care
- IRMD Health Care
- Exchange
- LENZ Nasdaq
- IRMD Nasdaq
- Market Cap
- LENZ 819.1M
- IRMD 668.2M
- IPO Year
- LENZ 2021
- IRMD 2014
- Fundamental
- Price
- LENZ $29.16
- IRMD $57.79
- Analyst Decision
- LENZ Strong Buy
- IRMD Strong Buy
- Analyst Count
- LENZ 5
- IRMD 1
- Target Price
- LENZ $41.80
- IRMD $72.00
- AVG Volume (30 Days)
- LENZ 180.2K
- IRMD 36.2K
- Earning Date
- LENZ 05-07-2025
- IRMD 07-31-2025
- Dividend Yield
- LENZ N/A
- IRMD 1.17%
- EPS Growth
- LENZ N/A
- IRMD 10.72
- EPS
- LENZ N/A
- IRMD 1.55
- Revenue
- LENZ N/A
- IRMD $75,154,639.00
- Revenue This Year
- LENZ N/A
- IRMD $10.62
- Revenue Next Year
- LENZ $534.98
- IRMD $9.69
- P/E Ratio
- LENZ N/A
- IRMD $37.46
- Revenue Growth
- LENZ N/A
- IRMD 11.04
- 52 Week Low
- LENZ $14.42
- IRMD $41.69
- 52 Week High
- LENZ $38.93
- IRMD $63.29
- Technical
- Relative Strength Index (RSI)
- LENZ 57.21
- IRMD 64.35
- Support Level
- LENZ $28.14
- IRMD $50.88
- Resistance Level
- LENZ $30.09
- IRMD $59.05
- Average True Range (ATR)
- LENZ 1.51
- IRMD 1.93
- MACD
- LENZ 0.01
- IRMD 0.57
- Stochastic Oscillator
- LENZ 76.97
- IRMD 84.58
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.